Member access

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 05/21 10:24:24 am
24050 ILa   +2.38%
05/21DJLaw Firm Advising Teva Dismisses Mylan Objections
05/21DJLaw Firm Advising Teva on Bid Dismisses Mylan's Objections to Its..
05/19 TEVA PHARMACEUT : ex-dividend day for interim dividend
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on TEVA PHARMACEUTICAL INDUST
05/21DJLaw Firm Advising Teva Dismisses Mylan Objections
05/21DJLaw Firm Advising Teva on Bid Dismisses Mylan's Objections to Its Involvement
05/20 TEVA PHARMACEUTICAL : Presents Further Data from Phase IIb with TEV-48125 in Chr..
05/19 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : ex-dividend day for interim dividend
05/18 Endo pushes further into generics with $8 billion Par Pharma buy
05/17 NOBLE ENERGY : BRIEF: George Soros exits Teva
05/15 TEVA PHARMACEUTICAL : An Application for the Trademark "BENDEKA" Has Been Filed ..
05/15 TEVA PHARMACEUTICAL : Trademark Application for "BENEETAH" Filed by Teva Pharmac..
05/15 TEVA PHARMACEUTICAL : Provides Additional Detail on Proposed Acquisition of Myla..
05/15 TEVA PHARMACEUTICAL : Reports First Quarter 2015 Results
05/15 TEVA PHARMACEUTICAL : to Present New Respiratory Data at 2015 Annual Internation..
05/15 TEVA PHARMACEUTICALS : USA's Trademark Application for "BENDELTA" Filed
05/14 TEVA PHARMACEUTICAL : Researchers Submit Patent Application, "Treatment of Multi..
05/14 TEVA PHARMACEUTICAL : Completes Acquisition of Auspex Pharmaceuticals
05/14 TEVA PHARMACEUTICAL : We can close Mylan deal in 2015
05/14 TEVA PHARMACEUTICAL : Presents Further Data from Phase IIb with TEV-48125 in Chr..
05/12 PERRIGO : Mylan mulling improved offer for Perrigo - Bloomberg
05/12 ACTAVIS CEO : Teva-Mylan deal could be "value-destroying"
05/12DJPerrigo to Buy Patheon's Mexican Business
05/12DJPerrigo to Buy Patheon's Mexican Business for $34 Million
05/12 TEVA PHARMACEUTICAL : Analyst says Mylan's moves not just about shareholders
05/12 TEVA PHARMACEUTICAL : Xenon Pharmaceuticals Reports First Quarter 2015 Financial..
05/11 PERRIGO : Teva rejected opportunity to acquire Perrigo
05/11 ANTARES PHARMA : Reports First Quarter 2015 Operating and Financial Results
05/10 TEVA PHARMACEUTICAL : Mylan chairman: We could buy Teva
05/10 TEVA PHARMACEUTICAL : Desheh: Copaxone has a long life ahead of it
05/08 EXCLUSIVE : Mylan chairman tells investors he would consider buying Teva
05/08 TEVA PHARMACEUTICAL : to Present at the Bank of America Merrill Lynch 2015 Healt..
05/07 Hapoalim, Sphera Fund hold Mylan
05/06 TEVA PHARMACEUTICAL : takeover supporter Paulson raises Mylan stake
05/06 Alexion to bolster rare disease offering with $8.4 billion deal
05/06 TEVA PHARMACEUTICAL : An Application for the Trademark "TREXALL" Has Been Filed ..
05/06 TEVA PHARMACEUTICAL : Trademark Application for "DURA MED" Filed by Teva Pharmac..
05/06 TEVA PHARMACEUTICAL : An Application for the Trademark "GATE" Has Been Filed by ..
05/06 TEVA PHARMACEUTICAL : Continues to Invigorate Injectable Portfolio with the Laun..
05/06 TEVA PHARMACEUTICAL : outlines positives of Mylan offer
05/05 AUSPEX PHARMACEUTICALS : Teva completes $3.2b acquisition of Auspex
05/05 TEVA PHARMACEUTICAL : Completes Acquisition of Auspex Pharmaceuticals
05/05 TEVA PHARMACEUTICAL : Provides Additional Detail on Proposed Acquisition of Myla..
05/04 BENNY LANDA : Teva would be wrong to buy Mylan
05/03 TEVA PHARMACEUTICAL : What does Mylan really think it's worth?
05/01DJDrug Maker Mylan Sues Law Firm Kirkland & Ellis
05/01 TEVA PHARMACEUTICAL : still pursuing merger with Mylan
04/30 TEVA PHARMACEUTICAL : CEO to Mylan chairman: You distort the picture
04/30 TEVA PHARMACEUTICAL : raises 2015 guidance
04/30 EXCLUSIVE : Pfizer is mystery bidder for rare disease drugmaker Sobi - sources
04/30DJTeva Raises Guidance as Generic-Medicine Segment Grows
04/30DJTeva Raises Guidance as Generic-Medicine Segment Grows
04/30 TEVA PHARMACEUTICAL : Reports First Quarter 2015 Results
04/30 TEVA PHARMACEUTICAL : Committed to Cash-and-Stock Acquisition of Mylan
04/29 Perrigo rejects raised Mylan bid; Teva recommits to Mylan buy
04/29 TEVA PHARMACEUTICAL : Sends Letter to Mylan Board
04/29 ACTIVE BIOTECH : Teva and Active Biotech Announce First Patient Enrolled in Phas..
04/29 TEVA PHARMACEUTICAL : Presents Data Comparing Early Treatment with COPAXONE® 40 ..
04/29 TEVA PHARMACEUTICAL : to Report First Quarter 2015 Financial Results on April 30..
04/29 PERRIGO : Mylan again boosts offer for drugmaker Perrigo
04/29DJMylan Boosts Offer for Perrigo to $35.6 Billion -- 2nd Update
04/29 Exclusive - Perrigo expected to reject Mylan's latest offer
04/29DJMylan Boosts Offer for Perrigo to $35.6 Billion
04/29DJMylan Boosts Offer for Perrigo to $35.6 Billion--Update
04/29DJMylan Boosts Offer for Perrigo to $35.6 Billion
04/28 TAMIR FISHMAN VENTURE CAPITAL II : Capital soars after court ruling against Teva
04/28 PERRIGO : "Even at $100 per share Teva's Mylan bid worthwhile"
04/28 TEVA PHARMACEUTICAL : Globes, Tel Aviv, Israel, Shiri Habib-Valdhorn column
04/28 PERRIGO : "Mylan chairman is uncouth with an enormous ego"
04/28 TEVA PHARMACEUTICAL : Launches Generic Abilify® Tablets in the United States
04/28 TEVA PHARMACEUTICAL : Mylan spurns $40B deal
04/28 TEVA PHARMACEUTICAL : Continues to Invigorate Injectable Portfolio with the Laun..
04/28 TEVA PHARMACEUTICAL : Issues Data Comparing Early Treatment with COPAXONE 40 mg/..
04/28 TEVA PHARMACEUTICAL : and Active Biotech: Patient Enrolled in Phase II Study Eva..
04/28 TEVA PHARMACEUTICAL : reiterates commitment to Cash-and-Stock acquisition of Myl..
04/27 BIOMARIN PHARMACEUTICAL : CRY Has A Reason To Smile, MDXG Lifts Outlook, MYL Rej..
04/27DJMylan Rejects Teva's Unsolicited $40 Billion Bid--4th Update
04/27DJU.S. Stocks End Lower
04/27DJADR Shares End Mixed; Teva Declines
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF